25 XP   0   0   10

Acticor Biotech SAS
Buy, Hold or Sell?

Let's analyse Acticor Biotech SAS together

PenkeI guess you are interested in Acticor Biotech SAS. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Acticor Biotech SAS. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Acticor Biotech SAS

I send you an email if I find something interesting about Acticor Biotech SAS.

Quick analysis of Acticor Biotech SAS (30 sec.)










What can you expect buying and holding a share of Acticor Biotech SAS? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€-0.14
Expected worth in 1 year
€-3.52
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
€-3.38
Return On Investment
-1,250.8%

For what price can you sell your share?

Current Price per Share
€0.27
Expected price per share
€0 - €2.77
How sure are you?
50%

1. Valuation of Acticor Biotech SAS (5 min.)




Live pricePrice per Share (EOD)

€0.27

Intrinsic Value Per Share

€-11.23 - €-6.43

Total Value Per Share

€-11.38 - €-6.57

2. Growth of Acticor Biotech SAS (5 min.)




Is Acticor Biotech SAS growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.4m$11.7m-$14.1m-591.2%

How much money is Acticor Biotech SAS making?

Current yearPrevious yearGrowGrow %
Making money-$17.8m-$14.1m-$3.6m-20.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Acticor Biotech SAS (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#903 / 1010

Most Revenue
#930 / 1010

Most Profit
#673 / 1010

Most Efficient
#371 / 1010

What can you expect buying and holding a share of Acticor Biotech SAS? (5 min.)

Welcome investor! Acticor Biotech SAS's management wants to use your money to grow the business. In return you get a share of Acticor Biotech SAS.

What can you expect buying and holding a share of Acticor Biotech SAS?

First you should know what it really means to hold a share of Acticor Biotech SAS. And how you can make/lose money.

Speculation

The Price per Share of Acticor Biotech SAS is €0.27. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Acticor Biotech SAS.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Acticor Biotech SAS, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-0.14. Based on the TTM, the Book Value Change Per Share is €-0.84 per quarter. Based on the YOY, the Book Value Change Per Share is €0.59 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Acticor Biotech SAS.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-1.08-400.7%-1.08-400.7%-0.86-318.2%-0.52-191.6%-0.34-124.8%
Usd Book Value Change Per Share-0.90-334.7%-0.90-334.7%0.63234.7%0.029.1%-0.14-50.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.90-334.7%-0.90-334.7%0.63234.7%0.029.1%-0.14-50.3%
Usd Price Per Share7.56-7.56-4.90-2.90-5.21-
Price to Earnings Ratio-6.98--6.98--5.71-12.64--12.91-
Price-to-Total Gains Ratio-8.36--8.36-7.73--0.01--19.86-
Price to Book Ratio-49.44--49.44-6.53--6.58--1.11-
Price-to-Total Gains Ratio-8.36--8.36-7.73--0.01--19.86-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.288954
Number of shares3460
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.900.02
Usd Total Gains Per Share-0.900.02
Gains per Quarter (3460 shares)-3,126.3584.78
Gains per Year (3460 shares)-12,505.41339.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-12505-125150339329
20-25011-250200678668
30-37516-37525010171007
40-50022-50030013561346
50-62527-62535016961685
60-75032-75040020352024
70-87538-87545023742363
80-100043-100050027132702
90-112549-112555030523041
100-125054-125060033913380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%5.08.02.033.3%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.06.00.040.0%9.06.00.060.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.015.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.06.00.040.0%9.06.00.060.0%

Fundamentals of Acticor Biotech SAS

About Acticor Biotech SAS

Acticor Biotech SAS operates as a clinical stage biopharmaceutical company that develops drugs for the treatment for acute thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets platelet glycoprotein VI. It's product glenzocimab is in Phase 2/3 clinical trial, as well as completed Phase 1b/2a for the treatment of acute ischemic stroke; and Phase 2/3 clinical trial for treatment of cerebrovascular accidents in emergency situations, as well as completed Phase 2 clinical trial for treating acute respiratory distress syndrome (covid-19). The company has collaboration agreement with the University of Birmingham for Phase 2b clinical trials of glenzocimab in treating heart attacks. The company was incorporated in 2013 and is headquartered in Paris, France.

Fundamental data was last updated by Penke on 2024-04-09 07:55:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Acticor Biotech SAS.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Acticor Biotech SAS earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Acticor Biotech SAS to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Acticor Biotech SAS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-2,619.8%+2,619.8%
5Y-2,619.8%10Y-1,322.3%-1,297.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--216.8%+216.8%
YOY--282.3%+282.3%
5Y-2,619.8%-436.8%-2,183.0%
10Y-1,322.3%-597.3%-725.0%
1.1.2. Return on Assets

Shows how efficient Acticor Biotech SAS is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Acticor Biotech SAS to the Biotechnology industry mean.
  • -128.5% Return on Assets means that Acticor Biotech SAS generated €-1.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Acticor Biotech SAS:

  • The MRQ is -128.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -128.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-128.5%TTM-128.5%0.0%
TTM-128.5%YOY-73.9%-54.7%
TTM-128.5%5Y-71.8%-56.7%
5Y-71.8%10Y-86.2%+14.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-128.5%-13.3%-115.2%
TTM-128.5%-12.8%-115.7%
YOY-73.9%-11.6%-62.3%
5Y-71.8%-13.8%-58.0%
10Y-86.2%-15.6%-70.6%
1.1.3. Return on Equity

Shows how efficient Acticor Biotech SAS is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Acticor Biotech SAS to the Biotechnology industry mean.
  • 0.0% Return on Equity means Acticor Biotech SAS generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Acticor Biotech SAS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-119.9%+119.9%
TTM-5Y-145.0%+145.0%
5Y-145.0%10Y-73.2%-71.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY-119.9%-14.9%-105.0%
5Y-145.0%-19.3%-125.7%
10Y-73.2%-20.1%-53.1%

1.2. Operating Efficiency of Acticor Biotech SAS.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Acticor Biotech SAS is operating .

  • Measures how much profit Acticor Biotech SAS makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Acticor Biotech SAS to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Acticor Biotech SAS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-2,493.7%+2,493.7%
5Y-2,493.7%10Y-1,258.5%-1,235.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM--238.5%+238.5%
YOY--288.4%+288.4%
5Y-2,493.7%-486.2%-2,007.5%
10Y-1,258.5%-628.4%-630.1%
1.2.2. Operating Ratio

Measures how efficient Acticor Biotech SAS is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Acticor Biotech SAS:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y37.600-37.600
5Y37.60010Y19.372+18.228
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM-3.310-3.310
YOY-3.838-3.838
5Y37.6005.679+31.921
10Y19.3727.823+11.549

1.3. Liquidity of Acticor Biotech SAS.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Acticor Biotech SAS is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.75 means the company has €1.75 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Acticor Biotech SAS:

  • The MRQ is 1.752. The company is able to pay all its short-term debts. +1
  • The TTM is 1.752. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.752TTM1.7520.000
TTM1.752YOY4.159-2.407
TTM1.7525Y2.601-0.850
5Y2.60110Y1.954+0.647
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7523.863-2.111
TTM1.7524.169-2.417
YOY4.1595.337-1.178
5Y2.6016.122-3.521
10Y1.9546.434-4.480
1.3.2. Quick Ratio

Measures if Acticor Biotech SAS is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Acticor Biotech SAS to the Biotechnology industry mean.
  • A Quick Ratio of 1.71 means the company can pay off €1.71 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Acticor Biotech SAS:

  • The MRQ is 1.707. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.707. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.707TTM1.7070.000
TTM1.707YOY3.852-2.145
TTM1.7075Y2.567-0.860
5Y2.56710Y1.862+0.705
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7073.504-1.797
TTM1.7073.991-2.284
YOY3.8525.371-1.519
5Y2.5676.088-3.521
10Y1.8626.395-4.533

1.4. Solvency of Acticor Biotech SAS.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Acticor Biotech SAS assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Acticor Biotech SAS to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.17 means that Acticor Biotech SAS assets are financed with 117.3% credit (debt) and the remaining percentage (100% - 117.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Acticor Biotech SAS:

  • The MRQ is 1.173. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.173. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.173TTM1.1730.000
TTM1.173YOY0.384+0.789
TTM1.1735Y0.654+0.520
5Y0.65410Y0.788-0.135
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1730.339+0.834
TTM1.1730.337+0.836
YOY0.3840.271+0.113
5Y0.6540.368+0.286
10Y0.7880.388+0.400
1.4.2. Debt to Equity Ratio

Measures if Acticor Biotech SAS is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Acticor Biotech SAS to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Acticor Biotech SAS:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.623-0.623
TTM-5Y1.516-1.516
5Y1.51610Y1.045+0.471
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.392-0.392
TTM-0.403-0.403
YOY0.6230.335+0.288
5Y1.5160.427+1.089
10Y1.0450.461+0.584

2. Market Valuation of Acticor Biotech SAS

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Acticor Biotech SAS generates.

  • Above 15 is considered overpriced but always compare Acticor Biotech SAS to the Biotechnology industry mean.
  • A PE ratio of -6.98 means the investor is paying €-6.98 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Acticor Biotech SAS:

  • The EOD is -0.267. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.984. Based on the earnings, the company is expensive. -2
  • The TTM is -6.984. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.267MRQ-6.984+6.717
MRQ-6.984TTM-6.9840.000
TTM-6.984YOY-5.706-1.278
TTM-6.9845Y12.642-19.626
5Y12.64210Y-12.905+25.547
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.267-2.300+2.033
MRQ-6.984-2.656-4.328
TTM-6.984-2.718-4.266
YOY-5.706-4.145-1.561
5Y12.642-6.258+18.900
10Y-12.905-6.315-6.590
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Acticor Biotech SAS:

  • The EOD is -0.350. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.157. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.157. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.350MRQ-9.157+8.807
MRQ-9.157TTM-9.1570.000
TTM-9.157YOY-5.227-3.930
TTM-9.1575Y-3.892-5.265
5Y-3.89210Y-26.565+22.673
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.350-2.974+2.624
MRQ-9.157-3.306-5.851
TTM-9.157-3.508-5.649
YOY-5.227-5.613+0.386
5Y-3.892-8.378+4.486
10Y-26.565-8.873-17.692
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Acticor Biotech SAS is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -49.44 means the investor is paying €-49.44 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Acticor Biotech SAS:

  • The EOD is -1.891. Based on the equity, the company is expensive. -2
  • The MRQ is -49.437. Based on the equity, the company is expensive. -2
  • The TTM is -49.437. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.891MRQ-49.437+47.547
MRQ-49.437TTM-49.4370.000
TTM-49.437YOY6.529-55.966
TTM-49.4375Y-6.579-42.858
5Y-6.57910Y-1.111-5.468
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.8911.914-3.805
MRQ-49.4372.116-51.553
TTM-49.4372.097-51.534
YOY6.5292.881+3.648
5Y-6.5793.550-10.129
10Y-1.1113.936-5.047
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Acticor Biotech SAS compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.844-0.8440%0.592-243%0.023-3788%-0.127-85%
Book Value Per Share---0.143-0.1430%0.701-120%0.328-144%0.595-124%
Current Ratio--1.7521.7520%4.159-58%2.601-33%1.954-10%
Debt To Asset Ratio--1.1731.1730%0.384+206%0.654+80%0.788+49%
Debt To Equity Ratio----0%0.623-100%1.516-100%1.045-100%
Dividend Per Share----0%-0%-0%-0%
Eps---1.011-1.0110%-0.803-21%-0.483-52%-0.315-69%
Free Cash Flow Per Share---0.771-0.7710%-0.876+14%-0.541-30%-0.307-60%
Free Cash Flow To Equity Per Share---0.299-0.2990%0.239-225%0.079-476%0.013-2383%
Gross Profit Margin--1.0001.0000%1.036-3%1.013-1%1.006-1%
Intrinsic Value_10Y_max---6.427--------
Intrinsic Value_10Y_min---11.234--------
Intrinsic Value_1Y_max---0.380--------
Intrinsic Value_1Y_min---0.811--------
Intrinsic Value_3Y_max---1.344--------
Intrinsic Value_3Y_min---2.723--------
Intrinsic Value_5Y_max---2.549--------
Intrinsic Value_5Y_min---4.935--------
Market Cap4240755.000-2515%110887890.000110887890.0000%71935770.000+54%42508071.600+161%76446676.800+45%
Net Profit Margin----0%-0%-26.1980%-13.2230%
Operating Margin----0%-0%-24.9370%-12.5850%
Operating Ratio----0%-0%37.600-100%19.372-100%
Pb Ratio-1.891+96%-49.437-49.4370%6.529-857%-6.579-87%-1.111-98%
Pe Ratio-0.267+96%-6.984-6.9840%-5.706-18%12.642-155%-12.905+85%
Price Per Share0.270-2515%7.0607.0600%4.580+54%2.706+161%4.867+45%
Price To Free Cash Flow Ratio-0.350+96%-9.157-9.1570%-5.227-43%-3.892-57%-26.565+190%
Price To Total Gains Ratio-0.320+96%-8.362-8.3620%7.733-208%-0.010-100%-19.860+138%
Quick Ratio--1.7071.7070%3.852-56%2.567-34%1.862-8%
Return On Assets---1.285-1.2850%-0.739-43%-0.718-44%-0.862-33%
Return On Equity----0%-1.1990%-1.4500%-0.7320%
Total Gains Per Share---0.844-0.8440%0.592-243%0.023-3788%-0.127-85%
Usd Book Value---2400458.600-2400458.6000%11791463.600-120%5513884.440-144%9993510.049-124%
Usd Book Value Change Per Share---0.904-0.9040%0.634-243%0.025-3788%-0.136-85%
Usd Book Value Per Share---0.153-0.1530%0.751-120%0.351-144%0.636-124%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.082-1.0820%-0.859-21%-0.517-52%-0.337-69%
Usd Free Cash Flow---12960122.000-12960122.0000%-14729162.600+14%-9094987.680-30%-5155106.953-60%
Usd Free Cash Flow Per Share---0.825-0.8250%-0.938+14%-0.579-30%-0.328-60%
Usd Free Cash Flow To Equity Per Share---0.319-0.3190%0.256-225%0.085-476%0.014-2383%
Usd Market Cap4538456.001-2515%118672219.878118672219.8780%76985661.054+54%45492138.226+161%81813233.511+45%
Usd Price Per Share0.289-2515%7.5567.5560%4.902+54%2.896+161%5.209+45%
Usd Profit---17802777.000-17802777.0000%-14134131.400-21%-10438944.840-41%-6450232.707-64%
Usd Revenue----0%-0%686469.944-100%8583464.935-100%
Usd Total Gains Per Share---0.904-0.9040%0.634-243%0.025-3788%-0.136-85%
 EOD+2 -6MRQTTM+0 -0YOY+10 -195Y+8 -2310Y+7 -24

3.2. Fundamental Score

Let's check the fundamental score of Acticor Biotech SAS based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.267
Price to Book Ratio (EOD)Between0-1-1.891
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.707
Current Ratio (MRQ)Greater than11.752
Debt to Asset Ratio (MRQ)Less than11.173
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.285
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Acticor Biotech SAS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5016.273
Ma 20Greater thanMa 503.445
Ma 50Greater thanMa 1003.943
Ma 100Greater thanMa 2003.657
OpenGreater thanClose0.310
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Total Stockholder Equity 6,2372,7969,033-7,3171,7169,30211,018-13,261-2,243
Net Debt  -8,991-2,756-11,7476,724-5,023-3,618-8,6419,9051,264



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets12,943
Total Liabilities15,186
Total Stockholder Equity-2,243
 As reported
Total Liabilities 15,186
Total Stockholder Equity+ -2,243
Total Assets = 12,943

Assets

Total Assets12,943
Total Current Assets11,737
Long-term Assets1,206
Total Current Assets
Cash And Cash Equivalents 6,599
Net Receivables 4,840
Other Current Assets 298
Total Current Assets  (as reported)11,737
Total Current Assets  (calculated)11,737
+/-0
Long-term Assets
Property Plant Equipment 14
Intangible Assets 713
Other Assets 479
Long-term Assets  (as reported)1,206
Long-term Assets  (calculated)1,206
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,701
Long-term Liabilities8,485
Total Stockholder Equity-2,243
Total Current Liabilities
Short-term Debt 801
Short Long Term Debt 801
Accounts payable 5,141
Other Current Liabilities 615
Total Current Liabilities  (as reported)6,701
Total Current Liabilities  (calculated)7,358
+/- 657
Long-term Liabilities
Long term Debt Total 7,062
Other Liabilities 1,423
Long-term Liabilities  (as reported)8,485
Long-term Liabilities  (calculated)8,485
+/-0
Total Stockholder Equity
Common Stock527
Retained Earnings -26,087
Accumulated Other Comprehensive Income -10
Capital Surplus 23,327
Total Stockholder Equity (as reported)-2,243
Total Stockholder Equity (calculated)-2,243
+/-0
Other
Capital Stock527
Cash and Short Term Investments 6,599
Common Stock Shares Outstanding 10,546
Current Deferred Revenue144
Liabilities and Stockholders Equity 12,943
Net Debt 1,264
Net Invested Capital 5,620
Net Tangible Assets -2,956
Net Working Capital 5,036
Property Plant and Equipment Gross 89
Short Long Term Debt Total 7,863



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
1,096
3,528
5,009
7,089
21,576
28,549
32,895
31,414
30,069
28,593
2,078
11,406
15,402
11,019
17,881
12,943
12,94317,88111,01915,40211,4062,07828,59330,06931,41432,89528,54921,5767,0895,0093,5281,096
   > Total Current Assets 
0
0
0
5,310
14,109
16,104
16,218
16,843
13,406
11,662
2,042
11,116
14,456
10,120
16,873
11,737
11,73716,87310,12014,45611,1162,04211,66213,40616,84316,21816,10414,1095,310000
       Cash And Cash Equivalents 
88
55
0
862
509
964
1,402
3,312
2,050
2,508
80
10,190
12,883
7,587
11,348
6,599
6,59911,3487,58712,88310,190802,5082,0503,3121,40296450986205588
       Short-term Investments 
241
1,919
0
2,076
8,812
6,853
4,269
5,985
2,062
407
391
15
1
6
0
0
0061153914072,0625,9854,2696,8538,8122,07601,919241
       Net Receivables 
274
688
1,782
2,085
4,641
8,121
10,017
7,214
9,011
7,483
4,059
2,185
1,384
1,930
4,281
4,840
4,8404,2811,9301,3842,1854,0597,4839,0117,21410,0178,1214,6412,0851,782688274
       Inventory 
49
46
94
81
38
59
74
87
74
361
195
164
188
604
1,243
0
01,243604188164195361748774593881944649
   > Long-term Assets 
0
0
0
1,779
7,467
12,446
16,677
14,571
16,663
16,930
36
290
946
899
1,008
1,206
1,2061,0088999462903616,93016,66314,57116,67712,4467,4671,779000
       Property Plant Equipment 
64
81
131
132
232
277
382
288
202
137
30
287
227
180
98
14
1498180227287301372022883822772321321318164
       Goodwill 
266
266
788
842
5,740
8,062
9,690
8,508
8,508
8,508
0
0
0
0
0
0
0000008,5088,5088,5089,6908,0625,740842788266266
       Long Term Investments 
0
0
0
0
0
0
162
146
137
138
261
153
0
0
0
0
0000153261138137146162000000
       Intangible Assets 
325
483
1,459
1,638
7,152
11,991
16,133
14,137
7,814
8,147
8,542
4,633
713
713
713
713
7137137137134,6338,5428,1477,81414,13716,13311,9917,1521,6381,459483325
       Other Assets 
0
134
120
98
0
0
0
0
65
0
59
96
30
100
197
479
4791971003096590650000981201340
> Total Liabilities 
687
2,135
3,615
5,027
6,088
10,861
13,460
12,945
12,956
11,950
6,119
5,169
6,369
9,303
6,863
15,186
15,1866,8639,3036,3695,1696,11911,95012,95612,94513,46010,8616,0885,0273,6152,135687
   > Total Current Liabilities 
647
984
2,131
2,563
4,061
9,013
13,353
9,112
8,342
8,181
4,650
4,103
5,162
6,382
4,057
6,701
6,7014,0576,3825,1624,1034,6508,1818,3429,11213,3539,0134,0612,5632,131984647
       Short-term Debt 
0
0
0
2,076
8,812
6,853
1,590
507
2,062
407
104
147
106
164
507
801
8015071641061471044072,0625071,5906,8538,8122,076000
       Short Long Term Debt 
0
0
0
0
0
0
1,590
5
56
43
2
63
3,169
335
461
801
8014613353,169632435651,590000000
       Accounts payable 
133
329
1,044
1,446
2,316
5,490
5,841
5,851
6,033
6,177
1,297
514
1,623
2,715
3,027
5,141
5,1413,0272,7151,6235141,2976,1776,0335,8515,8415,4902,3161,4461,044329133
       Other Current Liabilities 
514
636
954
1,111
1,733
3,522
5,921
2,754
2,309
2,000
3,249
3,442
183
-1
1
615
6151-11833,4423,2492,0002,3092,7545,9213,5221,7331,111954636514
   > Long-term Liabilities 
0
0
0
2,464
2,026
1,849
107
3,833
4,614
3,770
1,469
1,066
1,207
2,921
2,806
8,485
8,4852,8062,9211,2071,0661,4693,7704,6143,8331071,8492,0262,464000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
1,030
2,400
2,200
7,062
7,0622,2002,4001,030000000000000
       Other Liabilities 
0
250
324
75
68
125
107
216
240
23
109
147
136
3,278
606
1,423
1,4236063,2781361471092324021610712568753242500
> Total Stockholder Equity
409
1,393
1,359
2,020
15,488
17,630
19,436
18,469
17,113
16,643
-4,041
6,237
9,033
1,716
11,018
-2,243
-2,24311,0181,7169,0336,237-4,04116,64317,11318,46919,43617,63015,4882,0201,3591,393409
   Common Stock
285
349
349
349
658
658
663
663
663
663
108
249
318
318
527
527
527527318318249108663663663663658658349349349285
   Retained Earnings 
119
90
2
422
1,669
2,227
1,662
-967
-1,356
-473
-5,121
-5,989
-5,053
-7,651
-12,796
-26,087
-26,087-12,796-7,651-5,053-5,989-5,121-473-1,356-9671,6622,2271,669422290119
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
27,397
11,639
23,319
23,327
23,32723,31911,63927,397000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
4,481
6,143
5,176
3,823
1,378
12,411
13,158
8,131
23,287
23,317
23,31723,2878,13113,15812,4111,3783,8235,1766,1434,481000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-86
Gross Profit-86-86
 
Operating Income (+$)
Gross Profit-86
Operating Expense-15,102
Operating Income-15,121-15,188
 
Operating Expense (+$)
Research Development10,761
Selling General Administrative3,569
Selling And Marketing Expenses0
Operating Expense15,10214,330
 
Net Interest Income (+$)
Interest Income8
Interest Expense-766
Other Finance Cost-20
Net Interest Income-778
 
Pretax Income (+$)
Operating Income-15,121
Net Interest Income-778
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-15,878-14,364
EBIT - interestExpense = -15,887
-15,878
-15,869
Interest Expense766
Earnings Before Interest and Taxes (EBIT)-15,121-15,112
Earnings Before Interest and Taxes (EBITDA)-15,026
 
After tax Income (+$)
Income Before Tax-15,878
Tax Provision-0
Net Income From Continuing Ops-15,878-15,878
Net Income-16,635
Net Income Applicable To Common Shares-15,878
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses15,102
Total Other Income/Expenses Net-757778
 

Technical Analysis of Acticor Biotech SAS
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Acticor Biotech SAS. The general trend of Acticor Biotech SAS is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Acticor Biotech SAS's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Acticor Biotech SAS.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.72 < 2.73 < 2.77.

The bearish price targets are: .

Tweet this
Acticor Biotech SAS Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Acticor Biotech SAS. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Acticor Biotech SAS Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Acticor Biotech SAS. The current macd is -0.25408842.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Acticor Biotech SAS price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Acticor Biotech SAS. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Acticor Biotech SAS price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Acticor Biotech SAS Daily Moving Average Convergence/Divergence (MACD) ChartActicor Biotech SAS Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Acticor Biotech SAS. The current adx is 24.25.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Acticor Biotech SAS shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Acticor Biotech SAS Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Acticor Biotech SAS. The current sar is 4.21.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Acticor Biotech SAS Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Acticor Biotech SAS. The current rsi is 16.27. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Acticor Biotech SAS Daily Relative Strength Index (RSI) ChartActicor Biotech SAS Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Acticor Biotech SAS. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Acticor Biotech SAS price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Acticor Biotech SAS Daily Stochastic Oscillator ChartActicor Biotech SAS Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Acticor Biotech SAS. The current cci is -520.02964197.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Acticor Biotech SAS Daily Commodity Channel Index (CCI) ChartActicor Biotech SAS Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Acticor Biotech SAS. The current cmo is -77.56301076.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Acticor Biotech SAS Daily Chande Momentum Oscillator (CMO) ChartActicor Biotech SAS Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Acticor Biotech SAS. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Acticor Biotech SAS Daily Williams %R ChartActicor Biotech SAS Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Acticor Biotech SAS.

Acticor Biotech SAS Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Acticor Biotech SAS. The current atr is 0.451472.

Acticor Biotech SAS Daily Average True Range (ATR) ChartActicor Biotech SAS Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Acticor Biotech SAS. The current obv is -1,124,828.

Acticor Biotech SAS Daily On-Balance Volume (OBV) ChartActicor Biotech SAS Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Acticor Biotech SAS. The current mfi is 51.63.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Acticor Biotech SAS Daily Money Flow Index (MFI) ChartActicor Biotech SAS Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Acticor Biotech SAS.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Acticor Biotech SAS Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Acticor Biotech SAS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5016.273
Ma 20Greater thanMa 503.445
Ma 50Greater thanMa 1003.943
Ma 100Greater thanMa 2003.657
OpenGreater thanClose0.310
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Acticor Biotech SAS with someone you think should read this too:
  • Are you bullish or bearish on Acticor Biotech SAS? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Acticor Biotech SAS? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Acticor Biotech SAS

I send you an email if I find something interesting about Acticor Biotech SAS.


Comments

How you think about this?

Leave a comment

Stay informed about Acticor Biotech SAS.

Receive notifications about Acticor Biotech SAS in your mailbox!